Get started
Author

Stefanie Dillenhöfer

Observed names: Dillenhöfer, Stefanie, S Dillenhöfer, S. Dillenhöfer
ORCID: 0000-0001-6020-8717
Observed ORCID: 0000-0001-6020-8717
OpenAlex ID: A5068940883
Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry
2023 · Sivagurunathan Sutharsan, Stefanie Dillenhoefer, et al. · The Lancet Regional Health - Europe · 83
Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
2020 · Sarah Dietz-Terjung, Wolfgang Gruber, et al. · Sleep And Breathing · 21
PDF
Associations between respiratory pathogens and lung function in primary ciliary dyskinesia: cross-sectional analysis from the PROVALF-PCD cohort
2024 · Bruna Rubbo, Avni Kant, et al. · ERJ Open Research · 20
PDF
Characterization of the L-Arginine/Nitric Oxide Pathway and Oxidative Stress in Pediatric Patients with Atopic Diseases
2022 · Beatrice Hanusch, Kathrin Sinningen, et al. · International Journal of Molecular Sciences · 19
PDF
Health-Related and Motor Performance-Related Fitness and Physical Activity Among Youth With Cystic Fibrosis
2021 · Wolfgang Gruber, Matthias Welsner, et al. · Perceptual and Motor Skills · 18
PDF
Natural variability of lung function in primary ciliary dyskinesia: longitudinal analysis from the PROVALF-PCD cohort
2025 · Kewei Zhang, Avni Kant, et al. · ERJ Open Research · 9
Long‐Term Pulmonary Sequelae 5–14 Years After Protracted Bacterial Bronchitis in Early Childhood
2025 · Jan Hermann, Karen Brückner, et al. · Pediatric Pulmonology · 8
PDF
Die induzierbare laryngeale Obstruktion (ILO) – Ursachen, klinische Präsentation, Diagnostik und Therapie: Positionspaper der Arbeitsgruppe „Dysfunktionelle Respiratorische Symptome“ der Gesellschaft für Pädiatrische Pneumologie (GPP)
2021 · S. Dillenhöfer, B. Hinrichs, et al. · Monatsschrift Kinderheilkunde · 7
PDF
293 Impact of elexacaftor-tezacaftor-ivacaftor on lung function, nutritional status, pulmonary exacerbation, and sweat chloride in people with cystic fibrosis: real-world evidence from German Cystic Fibrosis Registry
2023 · S. Sutharsan, S. Dillenhöfer, et al. · Journal of Cystic Fibrosis · 6
PDF
Move-PCD—a multi-center longitudinal randomized controlled superiority trial on the effect of a 6-month individualized supported physical activity (PA) program on quality of life (QoL) in children, adolescents, and adults with primary ciliary dyskinesia
2024 · Anna Teresa Hoffmann, Anna Mai, et al. · Trials · 5
PDF
Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis Registry
2025 · Stefanie Dillenhöfer, Katharina Schütz, et al. · ERJ Open Research · 3
Taste and Smell Disorders in Children and Young Adults With Cystic Fibrosis and Primary Ciliary Dyskinesia—A Prospective Comparative Study
2025 · Lea Christiane Beermann, Lisa Sophie Demski, et al. · Pediatric Pulmonology · 2
PDF
Herausforderungen der Therapie thorakaler Schmerzen bei zystischer Fibrose (CF)
2021 · A. T. Hoffmann, S. Dillenhöfer, et al. · Der Schmerz · 2
PDF
Analysis of risk factors for protracted bacterial bronchitis in infancy and long-term sequelae
2023 · Anne Schlegtendal, Karen Brückner, et al. · European Respiratory Journal · 1
Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
2020 · Sarah Dietz-Terjung, Wolfgang Gruber, et al. · Journal of Thoracic Disease · 1
PDF
CFTR Complex Alleles in Individuals with Cystic Fibrosis Showing Limited Response to Elexacaftor/Tezacaftor/Ivacaftor (ETI) Triple Modulator Therapy
2026 · Maike Karnstedt, Katharina Schütz, et al. · Research Square
PDF
Move-PCD – Eine multizentrische, randomisierte, kontrollierte Langzeitstudie zur Wirkung eines sechsmonatigen, individuell angepassten und betreuten Bewegungsprogramms auf die Lebensqualität von Menschen mit PCD
2026 · S Dillenhöfer, A Hoffmann, et al. · Klinische Pädiatrie
Move-PCD – A longitudinal randomised controlled trial of the effect of a physical activity program on quality of life in children and adults with PCD
2025 · Anne Schlegtendal, Anna Teresa Hoffmann, et al. · European Respiratory Journal
Neutropenie mit gewissen Extras
2025 · S Dillenhöfer, A T Hoffmann, et al. · Klinische Pädiatrie
Move-PCD – A multi-center longitudinal randomized controlled trial on the effect of a 6-month individualized and supervised physical activity (PA) program on quality of life (QoL) in children, adolescents, and adults with primary ciliary dyskinesia
2025 · A T Hoffmann, A Schlegtendal, et al. · Klinische Pädiatrie
Comparison of olfactory and gustatory function in children and adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia with healthies
2024 · Anne Schlegtendal, Lea Christiane Beermann, et al. · European Respiratory Journal
Move-PCD: A multicentre longitudinal randomized controlled trial on the effect of a 6-month individualized and supervised physical activity program on quality of life in children, adolescents, and adults with Primary Ciliary Dyskinesia
2024 · Stefanie Dillenhöfer, Anna Teresa Hoffmann, et al. · European Respiratory Journal
Thermal and mechanical pain thresholds in children and young adults with cystic fibrosis and primary ciliary dyskinesia
2024 · Stefanie Dillenhöfer, Lisa Sophie Demski, et al. · European Respiratory Journal
Editorial
2024 · Anna Wiemers, Stefanie Dillenhöfer, et al. · Klinische Pädiatrie
Experimentelle Bestimmung der thermischen und mechanischen Schmerzschwellen bei Kindern und jungen Erwachsenen mit Cystischer Fibrose und Primärer Ciliärer Dyskinesie
2024 · L. S. Demski, L. C. Beermann, et al. · Klinische Pädiatrie
Works count: 40
Citation count: 205
H-index: 7
I10-index: 5
Year
Topic
Type